However, other studies have shown that MMP2 and MMP9 are upregulated in cancer cells through a HIF1 -dependent mechanism, whereas MMP14 is upregulated in a HIF2-dependent manner, and their enhanced activity is due to increased expression of HIF-dependent urokinase-type plasminogen activator surface receptors (183). This evidence concerns the gene MMP9 and cancer.